The relation between lipoprotein(a) [Lp(a)], apolipoprotein (apo) E phenotypes, cholesterol, triglycerides, apo A-I, apo B, and a family history of atherosclerosis or risk factors was studied in 2-and 4-year-old French Caucasian children (n = 499). Lp(a) concentrations were distributed in a typical skewed manner and were found to be an independent lipid variable. 
The relation between lipoprotein(a) [Lp(a)], apolipoprotein (apo) E phenotypes, cholesterol, triglycerides, apo A-I, apo B, and a family history of atherosclerosis or risk factors was studied in 2-and 4-year-old French Caucasian children (n = 499). Lp(a) concentrations were distributed in a typical skewed manner and were found to be an independent lipid variable. The distribution of apo E phenotypes did not differ by gender. Cholesterol and apo B were under apo E phenotype control; Lp(a) was not. A significant positive relation was found between Lp(a) concentrations and the number of parental risk factors.
Children whose grandparents had a history of cardiovascular disease had Lp(a) concentrations shifted towards higher values. Measurement of Lp(a) in children may help to identify those at an increased risk of atherosclerotic disease, especially when their parents have at least two relevant risk factors.
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Lipoprotein(a)
[Lp(a)1 is a cholesterol-rich lipoprothin composed of a low-density lipoprotein (LDL) particle in which apolipoprotein (apo) B-100 is covalently linked to apo(a), a highly glycosylated protein that exhibits considerable size heterogeneity (molecular mass range 200-800 kDa). 5 The molecular mass of Lp(a) is genetically controlled and determines, at least in part, the concentrations of Lp(a) in plasma. Apo(a) serves to quantify Lp(a) (1, 2) . Epidemiological studies have established a link between high concentrations of Lp(a) and an increased risk of early coronary heart disease (3, 4) and stroke
The mechanism by which Lp(a) is atherogenic is not known; however, it appears to involve not only the lipoprotein character of Lp(a) but also a possible effect on fibrinolysis.
Indeed, Lp(a) has antithrombolytic properties, competing directly with plasminogen for the plasminogen receptor and thereby interfering with clot lysis.
Apo E plays a critical role in the metabolism of 'Department of Biochemistry,
triglyceride-rich lipoproteins
and cholesterol homeostasis.
The genetic polymorphism of apo E results from the existence of three codominant alleles (#{128}2, #{128}3, #{128}4), which code for three apo isoforms: E2, E3, and E4. Epidemiological studies have found the #{128}2 allele to be associated with low concentrations of cholesterol and LDL cholesterol, whereas #{128}4 is associated with high concentrations of both species and early onset of coronary heart disease and atherosclerosis (6) . The E31E3 phenotype is less frequent in subjects who have had a complete stroke or transient ischemic attack than in healthy blood donors (7) .
Because the atherosclerotic process begins early in life, the aims of this study were: (a) to determine, during a routine health check, For clarity of the figure, data from four subjects with Lp(a) >1200 mg/L (two subjects with none, one subject with two atherosclerosisrisk factors, and one subject whose risk factors were not documented) and data from children with one atherosclerotic risk factor in parents were not included. (11) . There are few studies on the influence of gender and age on Lp(a) in children. Rifai et al (12) reported no difference between males and females at birth. In our study, the 2-year-old boys had higher Lp(a) concentrations than the 2-yearold girls, and Lp(a) concentrations were not significantly different between 4-year-old boys and girls. The Bogalusa Heart Study showed that 8-17-year-old females had slightly higher Lp(a) values than 8-17-yearold males (10 (19) . This discrepancy may due to differences in age ranges of studied children. We also found that children whose parents reported having two risk factors had higher concentrations of Lp(a) than those whose parents had no risk factors and, the greater the number of risk factors, the higher the Lp(a) concentration.
To our knowledge, no such relationship has previously been reported. Moreover, apo B and cholesterol concentration were, and Lp(a) concentration levels were not, related to the presence of hyperlipidemia in the parents or grandparents. These results suggest that Lp(a) and LDL might contribute to atherogenesis through different mechanisms. Lp(a) consists of an LDL particle linked to apo(a). In contrast to the apo B concentration, the Lp(a) concentration is not influenced by apo E polymorphism. Variations in apo B and cholesterol concentrations dependent on apo E polymorphism were observed in these children, as has been previously reported in adults. However, when we evaluated the percentiles of Lp(a) according to apo E phenotypes, the E41E3 phenotypes were associated with lower Lp(a) values than were the E3/E3 and E31E2 phenotypes, especially in males (data not shown), even though this effect was modulated by the highly skewed distribution. Conflicting findings about the influence of apo E phenotypes on Lp(a) have been previously reported in adults (20, 21) . To our knowledge, there is no other study in children. Data from our study reinforce the hypothesis that concentrations of Lp(a) and LDL (apo B) in serum may be under separate metabolic control (22).
In conclusion, this study provides sex-and agespecific values for serum Lp(a) 
